STOCK TITAN
  1. Home
  2. Sec-filings
  3. CALC
  4. [Form 4] CalciMedica, Inc. Insider Trading Activity

[Form 4] CalciMedica, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock CALC logo
CALCIMEDICA INC

NASDAQ:CALC

CALC Rankings

#8372 Ranked by Market Cap
N/A Ranked by Dividends
#34 Top Gainer

CALC Latest News

Jul 8, 2025
CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference
Jun 25, 2025
CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure
Jun 12, 2025
CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting
May 14, 2025
CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
Apr 17, 2025
CalciMedica Announces Presentations at Upcoming Medical Meetings

CALC Latest SEC Filings

Jul 16, 2025
[Form 4] CalciMedica, Inc. Insider Trading Activity
Jul 10, 2025
[Form 4] CalciMedica, Inc. Insider Trading Activity
Jul 2, 2025
[Form 4] CalciMedica, Inc. Insider Trading Activity
Jun 27, 2025
[Form 4] CalciMedica, Inc. Insider Trading Activity
Jun 27, 2025
[S-8 POS] CalciMedica, Inc. SEC Filing

CALC Stock Data

22.22M
11.67M
17.6%
52.45%
0.72%
Biotechnology
Pharmaceutical Preparations
Link
United States
LA JOLLA